Alison L. Hannah - Net Worth and Insider Trading
Alison L. Hannah Net Worth
The estimated net worth of Alison L. Hannah is at least $646,361 dollars as of 2024-11-09. Alison L. Hannah is the Director of NeoGenomics Inc and owns about 38,782 shares of NeoGenomics Inc (NEO) stock worth over $611,592. Alison L. Hannah is also the Chief Medical Officer of CytomX Therapeutics Inc and owns about 31,898 shares of CytomX Therapeutics Inc (CTMX) stock worth over $34,769. Details can be seen in Alison L. Hannah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alison L. Hannah has not made any transactions after 2022-07-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alison L. Hannah
Alison L. Hannah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alison L. Hannah owns 3 companies in total, including NeoGenomics Inc (NEO) , CytomX Therapeutics Inc (CTMX) , and Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Alison L. Hannah’s form 4 insider trades.
Insider Ownership Summary of Alison L. Hannah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NEO | NeoGenomics Inc | 2018-06-01 | director |
| CTMX | CytomX Therapeutics Inc | 2022-07-20 | Chief Medical Officer |
| RIGL | Rigel Pharmaceuticals Inc | 2022-05-20 | director |
Alison L. Hannah Latest Holdings Summary
Alison L. Hannah currently owns a total of 2 stocks. Among these stocks, Alison L. Hannah owns 38,782 shares of NeoGenomics Inc (NEO) as of July 27, 2017, with a value of $611,592 and a weighting of 94.62%. Alison L. Hannah also owns 31,898 shares of CytomX Therapeutics Inc (CTMX) as of July 20, 2022, with a value of $34,769 and a weighting of 5.38%.
Latest Holdings of Alison L. Hannah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NEO | NeoGenomics Inc | 2017-07-27 | 38,782 | 15.77 | 611,592 |
| CTMX | CytomX Therapeutics Inc | 2022-07-20 | 31,898 | 1.09 | 34,769 |
Holding Weightings of Alison L. Hannah
Alison L. Hannah Form 4 Trading Tracker
According to the SEC Form 4 filings, Alison L. Hannah has made a total of 0 transactions in NeoGenomics Inc (NEO) over the past 5 years. The most-recent trade in NeoGenomics Inc is the acquisition of 20,000 shares on July 27, 2017, which cost Alison L. Hannah around $183,800.
According to the SEC Form 4 filings, Alison L. Hannah has made a total of 1 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 5,602 shares on July 20, 2022, which brought Alison L. Hannah around $7,955.
Insider Trading History of Alison L. Hannah
- 1
Alison L. Hannah Trading Performance
GuruFocus tracks the stock performance after each of Alison L. Hannah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alison L. Hannah is 10.89%. GuruFocus also compares Alison L. Hannah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alison L. Hannah within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alison L. Hannah's insider trading performs compared to the benchmark.
Performance of Alison L. Hannah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.32 | | | | | |
| Relative Return to S&P 500(%) | 0.99 | | | | | |
Alison L. Hannah Ownership Network
Ownership Network List of Alison L. Hannah
Ownership Network Relation of Alison L. Hannah
Alison L. Hannah Owned Company Details
What does NeoGenomics Inc do?
Who are the key executives at NeoGenomics Inc?
Alison L. Hannah is the director of NeoGenomics Inc. Other key executives at NeoGenomics Inc include General Counsel Alicia C Olivo , Chief Accounting Officer Greg D Aunan , and Chief Financial Officer Jeffrey Scott Sherman .
NeoGenomics Inc (NEO) Insider Trades Summary
Over the past 18 months, Alison L. Hannah made no insider transaction in NeoGenomics Inc (NEO). Other recent insider transactions involving NeoGenomics Inc (NEO) include a net sale of 7,345 shares made by Alicia C Olivo , and a net sale of 6,112 shares made by Lynn A. Tetrault .
In summary, during the past 3 months, insiders sold 1,040 shares of NeoGenomics Inc (NEO) in total and bought 0 shares, with a net sale of 1,040 shares. During the past 18 months, 13,457 shares of NeoGenomics Inc (NEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,457 shares.
NeoGenomics Inc (NEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeoGenomics Inc Insider Transactions
Alison L. Hannah Mailing Address
Above is the net worth, insider trading, and ownership report for Alison L. Hannah. You might contact Alison L. Hannah via mailing address: 12701 Commonwealth Drive, Suite 9, Fort Myers Fl 33913.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
